News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
860,565 Results
Type
Article (87415)
Company Profile (759)
Press Release (772366)
Multimedia
Podcasts (172)
Webinars (28)
Section
Business (233049)
Career Advice (4139)
Deals (39794)
Drug Delivery (135)
Drug Development (91245)
Employer Resources (203)
FDA (18277)
Job Trends (17399)
News (397375)
Policy (39925)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (124)
Alliances (56979)
ALS (145)
Alzheimer's disease (1680)
Antibody-drug conjugate (ADC) (232)
Approvals (18293)
Artificial intelligence (484)
Autoimmune disease (71)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (158)
Biotechnology (484)
Bladder cancer (124)
Brain cancer (52)
Breast cancer (481)
Cancer (3847)
Cardiovascular disease (337)
Career advice (3556)
Career pathing (38)
CAR-T (245)
CDC (57)
Cell therapy (678)
Cervical cancer (32)
Clinical research (75361)
Collaboration (1372)
Company closure (4)
Compensation (932)
Complete response letters (59)
COVID-19 (2954)
CRISPR (81)
C-suite (583)
Cystic fibrosis (133)
Data (4329)
Decentralized trials (2)
Denatured (61)
Depression (109)
Diabetes (451)
Diagnostics (7089)
Digital health (36)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (230)
Drug pricing (188)
Drug shortages (36)
Duchenne muscular dystrophy (202)
Earnings (98779)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132891)
Executive appointments (986)
FDA (20708)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (1248)
Gene editing (173)
Generative AI (48)
Gene therapy (545)
GLP-1 (1016)
Government (5381)
Grass and pollen (7)
Guidances (339)
Healthcare (20937)
HIV (48)
Huntington's disease (37)
IgA nephropathy (56)
Immunology and inflammation (240)
Immuno-oncology (20)
Indications (52)
Infectious disease (3188)
Inflammatory bowel disease (186)
Inflation Reduction Act (15)
Influenza (94)
Intellectual property (186)
Interviews (815)
IPO (17926)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (15)
Labor market (77)
Layoffs (640)
Leadership (33)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (548)
Lymphoma (263)
Machine learning (29)
Management (66)
Manufacturing (635)
MASH (138)
Medical device (14866)
Medtech (14889)
Mergers & acquisitions (22740)
Metabolic disorders (1147)
Multiple sclerosis (137)
NASH (23)
Neurodegenerative disease (227)
Neuropsychiatric disorders (60)
Neuroscience (2706)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (57)
Obesity (555)
Opinion (311)
Ovarian cancer (128)
Pain (163)
Pancreatic cancer (168)
Parkinson's disease (240)
Partnered (30)
Patents (413)
Patient recruitment (308)
Peanut (57)
People (66243)
Pharmaceutical (144)
Pharmacy benefit managers (27)
Phase I (23239)
Phase II (32716)
Phase III (24621)
Pipeline (2681)
Policy (295)
Postmarket research (3554)
Preclinical (10492)
Press Release (72)
Prostate cancer (196)
Psychedelics (51)
Radiopharmaceuticals (282)
Rare diseases (664)
Real estate (7421)
Recruiting (78)
Regulatory (27970)
Reports (65)
Research institute (2688)
Resumes & cover letters (651)
Rett syndrome (15)
RNA editing (15)
RSV (70)
Schizophrenia (134)
Series A (207)
Series B (156)
Service/supplier (30)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (100)
Tariffs (95)
The Weekly (109)
Vaccines (1039)
Venture capital (66)
Weight loss (393)
Women's health (58)
Worklife (21)
Date
Today (131)
Last 7 days (560)
Last 30 days (2510)
Last 365 days (33510)
2025 (26101)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1279)
Alabama (80)
Alaska (7)
Arizona (302)
Arkansas (14)
Asia (50935)
Australia (8955)
California (9373)
Canada (2846)
China (883)
Colorado (400)
Connecticut (420)
Delaware (261)
Europe (117054)
Florida (1378)
Georgia (314)
Hawaii (3)
Idaho (67)
Illinois (809)
India (51)
Indiana (458)
Iowa (19)
Japan (314)
Kansas (124)
Kentucky (38)
Louisiana (20)
Maine (77)
Maryland (1270)
Massachusetts (7060)
Michigan (312)
Minnesota (560)
Mississippi (4)
Missouri (119)
Montana (33)
Nebraska (26)
Nevada (106)
New Hampshire (77)
New Jersey (2599)
New Mexico (32)
New York (2552)
North Carolina (1409)
North Dakota (10)
Northern California (4219)
Ohio (294)
Oklahoma (22)
Oregon (50)
Pennsylvania (1958)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (48)
South Dakota (1)
Southern California (3587)
Tennessee (149)
Texas (1473)
United States (34708)
Utah (281)
Virginia (247)
Washington D.C. (83)
Washington State (812)
West Virginia (4)
Wisconsin (96)
Wyoming (1)
There are 860,565 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors
October 16, 2025
·
4 min read
Press Releases
PharmaTher Advances Phase 3 FDA Package for Ketamine in LID-Parkinson’s Disease
Company preparing FDA meeting package to align on a single, well-controlled Phase 3 study under 505(b)(2); Pharma partner discussions ongoing
October 16, 2025
·
6 min read
Press Releases
Pharmaceutical Excipients Market Size Expanding USD 15.43 Billion by 2034 Driven by Advanced Drug Formulations and Bio-Derived Excipients
October 16, 2025
·
1 min read
Press Releases
Gynecology Drugs Market Size to Reach USD 112.6 Billion by 2034 Rising Gynecological Disorders and Health Awareness Drive Market Growth
The global gynecology drugs market size is forecasted to reach around USD 112.6 billion by 2034, increasing from USD 69.79 billion in 2024 and representing a remarkable CAGR of 4.9% from 2025 to 2034.
October 16, 2025
·
1 min read
Press Releases
MMS Named Finalist in the Fierce Life Sciences Innovation Awards for KerusCloud® Clinical Trial Simulation Platform
October 16, 2025
·
1 min read
Layoff Tracker
Cuts Continue as Novo Restructuring Moves Forward
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
October 16, 2025
·
72 min read
·
BioSpace Editorial Staff
Press Releases
Hemostemix Adds the Treatment of Refractory Angina to Its Phase 1 Basket Protocol
October 16, 2025
·
11 min read
Press Releases
Model Medicines To Present Preclinical Data Readout for MDL-001, a Direct-Acting, Broad-Spectrum Antiviral Targeting a Novel Viral Mechanism, at IDWeek™ 2025
Data Presented At IDWeek 2025 To Demonstrate Broad-Spectrum Antiviral Activity And In Vivo Proof-of-Concept Across Both Respiratory And Liver Viruses
October 16, 2025
·
1 min read
IN PARTNERSHIP WITH PII
Work Smart, Build Trust: Connecting Technology, Patient Compliance and Data Processing
In this episode presented by PII, BioSpace’s head of insights discusses decentralized clinical studies and how connected technology can improve patient compliance with guests Oliver Eden and Travis Webb.
October 16, 2025
·
1 min read
·
BioSpace Insights
Autoimmune disease
Sanofi Joins With EVOQ in $500M Autoimmune Alliance
The partners have yet to disclose what their priority indications are, though EVOQ’s NanoDisc technology aims to enable the development of potentially curative treatments for autoimmune conditions such as celiac disease and type 1 diabetes.
October 16, 2025
·
2 min read
·
Tristan Manalac
1 of 86,057
Next
